Molecular Characterization Reveals Subclasses of 1q Gain in Intermediate Risk Wilms Tumors.
van Belzen IAEM, van Tuil M, Badloe S, Strengman E, Janse A, Verwiel ETP, van der Leest DFM, de Vos S, Baker-Hernandez J, Groenendijk A, de Krijger R, Kerstens HHD, Drost J, van den Heuvel-Eibrink MM, Tops BBJ, Holstege FCP, Kemmeren P, Hehir-Kwa JY.
van Belzen IAEM, et al. Among authors: strengman e.
Cancers (Basel). 2022 Oct 5;14(19):4872. doi: 10.3390/cancers14194872.
Cancers (Basel). 2022.
PMID: 36230794
Free PMC article.